Boris Kantor

Research Professor of Neurobiology

Kantor Lab, the Duke University Viral Vector Core, facilitates the use of virus-mediated tools for gene transfer by investigators across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, aging, cancer biology and others. Services are open to researchers within the Duke University Medical Center, Duke University, as well as outside investigators, worldwide.

Appointments and Affiliations

  • Research Professor of Neurobiology
  • Faculty Network Member of the Duke Institute for Brain Sciences

Contact Information

  • Office Location: Bryan Research Building, 311 Research Drive Room 213, Durham, NC 27710
  • Email Address: boris.kantor@duke.edu

Education

  • Ph.D. Grodno State Medical University (Republic of Belarus), 1995
  • M.Sc. The Hebrew University of Jerusalem (Israel), 1998
  • Ph.D. The Hebrew University of Jerusalem (Israel), 2005
  • University of North Carolina, Chapel Hill, 2009

Courses Taught

  • NEUROSCI 494: Research Independent Study 2

Representative Publications

  • Kantor, Boris, Bernadette O’Donovan, Joseph Rittiner, Dellila Hodgson, Nicholas Lindner, Sophia Guerrero, Wendy Dong, Austin Zhang, and Ornit Chiba-Falek. “The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders.” Nat Commun 15, no. 1 (August 23, 2024): 7259. https://doi.org/10.1038/s41467-024-50515-6.
  • Kantor, Boris, Bernadette Odonovan, Joseph Rittiner, Dellila Hodgson, Nicholas Lindner, Sophia Guerrero, Wendy Dong, Austin Zhang, and Ornit Chiba-Falek. “All-in-one AAV-delivered epigenome-editing platform: proof-of-concept and therapeutic implications for neurodegenerative disorders.” BioRxiv, May 19, 2024. https://doi.org/10.1101/2023.04.14.536951.
  • Sun, Zhiguo, Boris Kantor, and Ornit Chiba-Falek. “Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies.” Mol Ther Nucleic Acids 35, no. 1 (March 12, 2024): 102084. https://doi.org/10.1016/j.omtn.2023.102084.
  • Rittiner, Joseph, Mohanapriya Cumaran, Sahil Malhotra, and Boris Kantor. “Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs.” Front Bioeng Biotechnol 10 (2022): 1035543. https://doi.org/10.3389/fbioe.2022.1035543.
  • Dong, Wendy, and Boris Kantor. “Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.” Viruses 13, no. 7 (July 1, 2021). https://doi.org/10.3390/v13071288.